Member Info for cjulien

lets also not forget that the NIH still hasnt published our progression to phase 3, which should bring awareness to potential us investors...

good luck to the traders... ive wanted to trade this so many time but never did... feels like the worst time to give it a try now as everything starting to align...

im very aware of where we are :) let the trolls be trolls, i couldnt care less!

yes 50... one can dream... that would mean a 10bn valuation... very far from where we are but not impossible considering the TAM and increasing evidence that vaccines alone won't be the solution.

im aiming for Numis' bullish scenario :)

Audio streams for Australia, New Zealand and the United States reach medical professionals worldwide. Promote your brand, cause or organization simply by advertising with us and you will certainly reach our health-professional target audience!

brilliantly delivered! day and night when compared to the home trial results session...
a lot of positive information there... nice change of tone from RM

and here is the link: https://peterattiamd.com/pauloffit2/

a bit off topic but a super interesting podcast from peter attia with a virologist.
getting clearer by the day that covid is sadly never going away, but should benefit sng.

although to get to that number of patients they would need to progress it phase 3 wouldnt they? if so that would probably give a nice positive signal to the market...

initiating a discussion with the indian government for potential forward orders really caught my attention!

Both hospitalized on placebo... thats what keeps everything together here... i get it that its no where enough data to be significant but its supportive of earlier beliefs and if sng001 can cure severe patients and keep milders one that are worsening at home its a huge win...

*or

dont think you ll have much opportunity to sell at 350-400...
we ll either tank on bad news to shoot straight up to 600-800 or more...

Take a good look at the stock chart going back one year... in a few weeks/months from now, this will look flat relative to where we ll be... relax, news will come and they will be positive.

what news?

it does mention synairgen

https://news.trust.org/item/20210325211932-tw1el

Topping up here to round up to 50k shares

Just curious to know what it is that takes so long in doing trial reviews... i understand its a lot of data to analyze but i cant figure out how it would take months of work... any insights from the experts?